Jeffrey Claude Pelletier — Northwestern Scholars

Education/Academic qualification

Organic Chemistry, PhD, University of Pennsylvania

… → 1995

Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
Watterson, D. M. (PD/PI), Mesulam, M.-M. (Other), Pelletier, J. C. (Other) & Tokars, V. L. (Other)
National Institute on Aging
9/1/16 → 5/31/18
Project: Research project
Preclinical Alzheimer's Disease Drug Development of Novel MAPK Inhibitors
Watterson, D. M. (PD/PI), Mesulam, M.-M. (Other), Pelletier, J. C. (Other) & Tokars, V. L. (Other)
National Institute on Aging
9/30/12 → 5/31/16
Project: Research project